Laurus Labs Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

According to media reports, the pharmaceutical company?s export revenue declined 47% to about $36 million in February, reflecting a significant slowdown in overseas sales.

Laurus Labs is a research-driven pharmaceutical and biotechnology company. It holds a leadership position in developing and manufacturing select Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) across anti-retroviral, oncology, cardiovascular, and gastro therapeutics.

On a consolidated basis, Laurus Labs net profit rose 172.65% to Rs 251.66 crore while net sales rose 25.67% to Rs 1778.29 crore in Q3 December 2025 over Q3 December 2024.

Powered by Capital Market - Live News

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 1027.95, up 1.44% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.04% on the day, quoting at 25713.95. The Sensex is at 83408.99, down 0.05%. Laurus Labs Ltd has slipped around 3.27% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has slipped around 1.73% in last one month and is currently quoting at 22494.9, up 0.1% on the day. The volume in the stock stood at 7.19 lakh shares today, compared to the daily average of 21.68 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 1030.5, up 1.47% on the day. Laurus Labs Ltd is up 88.01% in last one year as compared to a 12.13% spurt in NIFTY and a 8.16% spurt in the Nifty Pharma index.

The PE of the stock is 68.35 based on TTM earnings ending December 25.

Powered by Capital Market - Live News

Laurus Labs Ltd is down for a fifth straight session today. The stock is quoting at Rs 944.45, down 2.13% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.8% on the day, quoting at 25118.1. The Sensex is at 81829.23, down 0.54%.Laurus Labs Ltd has lost around 14.65% in last one month.Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has eased around 5.07% in last one month and is currently quoting at 21715.1, down 0.37% on the day. The volume in the stock stood at 11.2 lakh shares today, compared to the daily average of 23.57 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 948.75, down 2.06% on the day. Laurus Labs Ltd jumped 61.07% in last one year as compared to a 7.52% rally in NIFTY and a 1.28% spurt in the Nifty Pharma index.

The PE of the stock is 65.08 based on TTM earnings ending December 25.

Powered by Capital Market - Live News

Net profit of Laurus Labs rose 172.65% to Rs 251.66 crore in the quarter ended December 2025 as against Rs 92.30 crore during the previous quarter ended December 2024. Sales rose 25.67% to Rs 1778.29 crore in the quarter ended December 2025 as against Rs 1415.05 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News